Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dectro International is a Canadian-based developer and manufacturer specializing in permanent hair removal and aesthetic skin care technologies. Established in 1978, the company is globally recognized for its Apilus brand, which utilizes advanced radiofrequency and electrolysis techniques to provide highly effective hair removal solutions. In addition to electrolysis, Dectro produces a wide array of medical-aesthetic equipment for treatments such as microdermabrasion, needle-free mesotherapy, and light therapy. The company also maintains a strong educational presence through its Académie Dectro, offering specialized training for professionals in the beauty and health sectors. Their products are distributed in over 35 countries, making them a significant player in the global aesthetics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dectro International.